A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
DEVELOPMENT AND VALIDATION OF MICROBIAL BIOASSAY FOR QUANTIFICATION OF CEPHALEXIN IN PHARMACEUTICAL PREPARATIONS
2017
International Research Journal of Pharmacy
The aim of this study was to develop and validate a simple, sensitive, precise and cost-effective one-level agar diffusion (5+1) bioassay for estimation of potency and bioactivity of Cephalexin in pharmaceutical preparation which has not yet been reported in any pharmacopoeia. Escherichia coli MTCC-443 was selected as the most significant strain against Cephalexin. Bioassay was optimized by investigating several factors such as buffer pH, inoculums concentration and reference standard
doi:10.7897/2230-8407.08696
fatcat:bddyn7jx2zexpcabfm5ymkxluy